Phase I trial to investigate the effect of renal impairment on isavuconazole pharmacokinetics
Crossref DOI link: https://doi.org/10.1007/s00228-017-2213-7
Published Online: 2017-03-07
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Townsend, Robert W.
Akhtar, Shahzad
Alcorn, Harry
Berg, Jolene K.
Kowalski, Donna L.
Mujais, Salim
Desai, Amit V.
Funding for this research was provided by:
Astellas Pharma Global Development
License valid from 2017-03-07